Current Report Filing (8-k)
March 08 2018 - 11:19AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 0R 15 (D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
March 6, 2018
Freedom Leaf Inc.
(Exact name of registrant as specified in
its charter)
Nevada
(State or Other Jurisdiction of Incorporation)
000-55687
|
46-2093679
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
|
3571 E. Sunset Road, Suite
420
Las Vegas, NV
|
89120
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
(877) 442-0411
(Registrant’s telephone number, including
area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
[_] Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[_] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[_] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [_]
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. [_]
|
Item 1.01
|
Entry into a Material Definitive Agreement.
|
On March 6, 2018, Leafceuticals Inc (the
“
Buyer
”), the wholly owned subsidiary of Freedom Leaf Inc., a Nevada corporation (the “
Company
”),
entered into an
Asset Purchase Agreement
(the “Agreement”) with Earth Born, Inc., a California corporation (“
Earth
Born California
”), Earth Born, Inc., a Delaware corporation (“
Earth Born Delaware
”), Irie Living,
a California nonprofit mutual benefit corporation (“
Irie
”), and Genesis Media Works, LLC, a Utah limited liability
company doing business as “Terra’s Way,” “Irie Hemp Company,” “Earth Born Botanicals,”
and “Santa Cruz Hemp Company” (“
Genesis
” and together with Earth Born California, Earth Born Delaware,
and Irie the “
Sellers
”) to acquire all of the Sellers’ assets (the “
Assets
”) associated
with and/or required to operate the Sellers’ CBD botanical and nutraceutical businesses (the “
Acquisition
”),
with an anticipated closing date of April 15, 2018.
In connection with the Acquisition, the
Buyer agreed to assume approximately $100,000 of liabilities associated with the Assets, and the purchase price for the Assets
is $2,200,000, subject to adjustment as described below, to be paid $400,000 in cash, and $1,800,000 via the issuance of an aggregate
of 7,826,087 shares of the Company’s common stock (the “
Shares
”) to the Sellers. The purchase price for
the Assets shall be reduced if (i) the Sellers’ aggregate pre-closing revenues for the year ending December 31, 2017, were
less than $1,600,000, or (ii) the Buyer’s average monthly revenues resulting from the Acquisition of the Assets for the three
months following closing are less than $120,000 per month. Additionally, 1,250,000 of the Shares shall be escrowed for 4 months
following Closing as the Buyer’s security for (i) any indemnification claims against the Sellers pursuant to the Agreement,
or (ii) any pre-closing or post-closing revenue deficiency resulting in the purchase price reductions described above. The escrowed
shares shall also be immediately released from escrow and paid to the Sellers as a “break fee” if the Buyer terminates
the Agreement prior to closing without cause.
The foregoing description of the Agreement
and its terms is qualified in its entirety by reference to the full text of the Agreement, which is attached hereto as Exhibit
10.1 to, and incorporated by reference in, this report.
Item 9.01 Financial Statements
and Exhibits.
The exhibits listed in the following Exhibit
Index are filed as part of this report:
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: March 8, 2018
FREEDOM LEAF INC.
By:
/s/ Clifford J. Perry
Clifford J. Perry
Chief Executive Officer